Examination Report |
1 | Power of Attorney | 16 Sep 2011 |
1 | TM-1 | 16 Sep 2011 |
10 | Hearing Notice | 04 Jul 2024 |
11 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 20 Aug 2024 |
12 | TM-M(EXTENSION OF TIME) | 20 Aug 2024 |
13 | Hearing Notice | 05 Sep 2024 |
14 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 15 Oct 2024 |
15 | Hearing Notice | 17 Oct 2024 |
16 | TM-M(REQUEST SUBMITTING AUTHORISATION OF AGENT) | 04 Nov 2024 |
2 | Additional Representation Sheet | 16 Sep 2011 |
2 | Power of Attorney | 16 Sep 2011 |
2 | TM-1 | 16 Sep 2011 |
3 | Additional Representation Sheet | 16 Sep 2011 |
3 | Power of Attorney | 16 Sep 2011 |
4 | TM-5 | 15 Feb 2013 |
5 | TM-6 | 19 Jul 2013 |
6 | Evidence Affidavit Under Rule 45 (TOP) | 18 Nov 2013 |
7 | Evidence Affidavit Under Rule 45 (TOP) | 18 Nov 2013 |
8 | Evidence Affidavit Under Rule 45 (TOP) | 18 Nov 2013 |
9 | Evidence Affidavit Under Rule 45 (TOP) | 18 Nov 2013 |
Trademark was applied on 16 September 2011 with IP India.
Proprietor of Ralofix is AUROBINDO PHARMA.
Class(es) in which the trademark was applied to is 5.
Status of Ralofix is Advertised bef acc.
Application number alloted to the trademark is 2206570.
Daswani & Daswani is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD